Interventional Oncology Market Size, Share, And Growth Report 2032

• Chapter 1. Introduction
  • 1.1. Report description and scope
  • 1.2. Research scope
  • 1.3. Research methodology
    • 1.3.1. Market research process
    • 1.3.2. Market research methodology
•  
• Chapter 2. Executive Summary
  • 2.1. Interventional Oncology Market, 2017-2025 (USD Million)
  • 2.2. Interventional Oncology Market: Snapshot
•  
• Chapter 3. Interventional Oncology Market - Industry Dynamics
  • 3.1. Introduction
  • 3.2. Market drivers
    • 3.2.1. Rapid Growth in the Geriatric Population
    • 3.2.2. Technological advancements
    • 3.2.3. Increasing government initiatives for cancer treatment
    • 3.2.4. Increasing awareness in developing nations
    • 3.2.5. Advanced research and development
    • 3.2.6. Increase in cancer patients due to changing lifestyle
    • 3.2.7. Growing elderly population
  • 3.3. Market restraints
    • 3.3.1. The high cost of treatment
    • 3.3.2. Lack of awareness in underdeveloped countries
    • 3.3.3. Lack of proper reimbursement policies
  • 3.4. Opportunities
    • 3.4.1. Evolving market
    • 3.4.2. Advanced technology
    • 3.4.3. Untapped Emerging Market
  • 3.5. Porter's Five Forces Analysis
  • 3.6. Market attractiveness analysis
    • 3.6.1. Market attractiveness analysis, by product
    • 3.6.2. Market attractiveness analysis, by cancer type
    • 3.6.3. Market attractiveness analysis, by procedure
    • 3.6.4. Market attractiveness analysis, by region
•  
• Chapter 4. Interventional Oncology Market - Competitive Landscape
  • 4.1. Company market share analysis
    • 4.1.1. Interventional oncology market: company market share, 2018
  • 4.2. Strategic development
    • 4.2.1. Acquisitions & mergers
    • 4.2.2. New instruments launch
    • 4.2.3. Agreements, partnerships, collaborations and joint ventures
    • 4.2.4. Research and development and regional expansion
•  
• Chapter 5. Interventional Oncology Market - Product Analysis
  • 5.1. Interventional oncology market: Product overview
    • 5.1.1. Interventional oncology Market Revenue, by product, 2018 and 2025
  • 5.2. Embolization Devices
    • 5.2.1. Interventional oncology market for embolization devices, 2017-2025 (USD Million)
  • 5.3. Ablation Devices
    • 5.3.1. Interventional oncology market for ablation devices, 2017-2025 (USD Million)
  • 5.4. Support Devices
    • 5.4.1. Interventional oncology market for support devices, 2017-2025 (USD Million)
•  
• Chapter 6. Interventional Oncology Market - Cancer Type Analysis
  • 6.1. Interventional oncology market: Cancer type overview
    • 6.1.1. Interventional oncology Market Revenue, by cancer type, 2018 and 2025
  • 6.2. Kidney
    • 6.2.1. Interventional oncology market for kidney cancer, 2017-2025 (USD Million)
  • 6.3. Lung
    • 6.3.1. Interventional oncology market for lung cancer, 2017-2025 (USD Million)
  • 6.4. Breast
    • 6.4.1. Interventional oncology market for breast cancer, 2017-2025 (USD Million)
  • 6.5. Liver
    • 6.5.1. Interventional oncology market for liver cancer, 2017-2025 (USD Million)
  • 6.6. Bone Metastasis
    • 6.6.1. Interventional oncology market for bone metastasis cancer, 2017-2025 (USD Million)
  • 6.7. Others
    • 6.7.1. Interventional oncology market for others, 2017-2025 (USD Million)
•  
• Chapter 7. Interventional Oncology Market - Procedure Analysis
  • 7.1. Interventional oncology market: procedure overview
    • 7.1.1. Interventional oncology market revenue, by procedure, 2018 and 2025
    • 7.1.2. Thermal Ablation
      • 7.1.2.1. Interventional oncology market for thermal ablation, 2017-2025 (USD Million)
    • 7.1.3. Non-Thermal Ablation
      • 7.1.3.1. Interventional oncology market for non-thermal ablation, 2017-2025 (USD Million)
    • 7.1.4. Transcatheter Arterial Chemoembolization
      • 7.1.4.1. Interventional oncology market for transcatheter arterial chemoembolization, 2017-2025 (USD Million)
    • 7.1.5. Transcatheter Arterial Radioembolization
      • 7.1.5.1. Interventional oncology market for transcatheter arterial radioembolization, 2017-2025 (USD Million)
    • 7.1.6. Transcatheter Arterial Embolization
      • 7.1.6.1. Interventional oncology market for transcatheter arterial embolization, 2017-2025 (USD Million)
•  
• Chapter 8. Interventional Oncology Market - Regional Analysis
  • 8.1. Global interventional oncology market: Regional overview
    • 8.1.1. Interventional oncology market revenue, by region, 2018 and 2025
  • 8.2. North America
    • 8.2.1. North America interventional oncology market revenue, by product, 2017-2025 (USD Million)
    • 8.2.2. North America interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
    • 8.2.3. North America interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
    • 8.2.4. The U.S.
      • 8.2.4.1. The U.S. interventional oncology market, by product, 2017-2025 (USD Million)
      • 8.2.4.2. The U.S. interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
      • 8.2.4.3. The U.S. interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
    • 8.2.5. Canada
      • 8.2.5.1. Canada interventional oncology market, by product, 2017-2025 (USD Million)
      • 8.2.5.2. Canada interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
      • 8.2.5.3. Canada interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe interventional oncology market revenue, by product, 2017-2025 (USD Million)
    • 8.3.2. Europe interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
    • 8.3.3. Europe interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
    • 8.3.4. UK
      • 8.3.4.1. UK interventional oncology market, by product, 2017-2025 (USD Million)
      • 8.3.4.2. UK interventional oncology market, by cancer type, 2017-2025 (USD Million)
      • 8.3.4.3. UK interventional oncology market, by procedure, 2017-2025 (USD Million)
    • 8.3.5. Germany
      • 8.3.5.1. Germany interventional oncology market revenue, by product, 2017-2025 (USD Million)
      • 8.3.5.2. Germany interventional oncology market, by cancer type, 2017-2025 (USD Million)
      • 8.3.5.3. Germany interventional oncology market, by procedure, 2017-2025 (USD Million)
    • 8.3.6. France
      • 8.3.6.1. France interventional oncology market revenue, by product, 2017-2025 (USD Million)
      • 8.3.6.2. France interventional oncology market, by cancer type, 2017-2025 (USD Million)
      • 8.3.6.3. France interventional oncology market, by procedure, 2017-2025 (USD Million)
    • 8.3.7. Rest of Europe
      • 8.3.7.1. Rest of Europe interventional oncology market revenue, by product, 2017-2025 (USD Million)
      • 8.3.7.2. Rest of Europe interventional oncology market, by cancer type, 2017-2025 (USD Million)
      • 8.3.7.3. Rest of Europe interventional oncology market, by procedure, 2017-2025 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific interventional oncology market revenue, by product, 2017-2025 (USD Million)
    • 8.4.2. Asia Pacific interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
    • 8.4.3. Asia Pacific interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
    • 8.4.4. China
      • 8.4.4.1. China interventional oncology market revenue, by product, 2017-2025 (USD Million)
      • 8.4.4.2. China interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
      • 8.4.4.3. China interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
    • 8.4.5. Japan
      • 8.4.5.1. Japan interventional oncology market revenue, byproduct, 2017-2025 (USD Million)
      • 8.4.5.2. Japan interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
      • 8.4.5.3. Japan interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
    • 8.4.6. India
      • 8.4.6.1. India interventional oncology market revenue, by product, 2017-2025 (USD Million)
      • 8.4.6.2. India interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
      • 8.4.6.3. India interventional oncology market revenue, by procedure type, 2017-2025 (USD Million)
    • 8.4.7. Rest of Asia Pacific
      • 8.4.7.1. Rest of Asia Pacific interventional oncology market revenue, by product, 2017-2025 (USD Million)
      • 8.4.7.2. Rest of Asia Pacific interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
      • 8.4.7.3. Rest of Asia Pacific interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America interventional oncology market revenue, by product, 2017-2025 (USD Million)
    • 8.5.2. Latin America interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
    • 8.5.3. Latin America interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
    • 8.5.4. Brazil
      • 8.5.4.1. Brazil interventional oncology market revenue, by product, 2017-2025 (USD Million)
      • 8.5.4.2. Brazil interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
      • 8.5.4.3. Brazil interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
    • 8.5.5. Rest of Latin America
      • 8.5.5.1. Rest of Latin America interventional oncology market revenue, by product, 2017-2025 (USD Million)
      • 8.5.5.2. Rest of Latin America interventional oncology market revenue, by cancer type, 2017-2025 (USD Million)
      • 8.5.5.3. Rest of Latin America interventional oncology market revenue, by procedure, 2017-2025 (USD Million)
  • 8.6. The Middle East and Africa
    • 8.6.1. The Middle East and Africa interventional oncology market revenue, by product, 2017-2025 (USD Million)
    • 8.6.2. The Middle East and Africa interventional oncology market, by cancer type, 2017-2025 (USD Million)
    • 8.6.3. The Middle East and Africa interventional oncology market, by procedure, 2017-2025 (USD Million)
•  
• Chapter 9. Company Profile
  • 9.1. Boston Scientific
    • 9.1.1. Overview
    • 9.1.2. Financials
    • 9.1.3. Product Portfolio
    • 9.1.4. Business Strategy
    • 9.1.5. Recent Developments
  • 9.2. Terumo Corporation
    • 9.2.1. overview
    • 9.2.2. Financials
    • 9.2.3. Product Portfolio
    • 9.2.4. Business Strategy
    • 9.2.5. Recent Developments
  • 9.3. Medtronic
    • 9.3.1. Overview
    • 9.3.2. Financials
    • 9.3.3. Product Portfolio
    • 9.3.4. Business Strategy
    • 9.3.5. Recent Developments
  • 9.4. BTG
    • 9.4.1. Overview
    • 9.4.2. Financials
    • 9.4.3. Product Portfolio
    • 9.4.4. Business Strategy
    • 9.4.5. Recent Developments
  • 9.5. Ethicon
    • 9.5.1. Overview
    • 9.5.2. Financials
    • 9.5.3. Product Portfolio
    • 9.5.4. Business Strategy
    • 9.5.5. Recent Developments
  • 9.6. AngioDynamics
    • 9.6.1. Overview
    • 9.6.2. Financials
    • 9.6.3. Product Portfolio
    • 9.6.4. Business Strategy
    • 9.6.5. Recent Developments
  • 9.7. Merit Medical Systems
    • 9.7.1. Overview
    • 9.7.2. Financials
    • 9.7.3. Product Portfolio
    • 9.7.4. Business Strategy
    • 9.7.5. Recent Developments
  • 9.8. Sirtex Medical
    • 9.8.1. Overview
    • 9.8.2. Financials
    • 9.8.3. Product Portfolio
    • 9.8.4. Business Strategy
    • 9.8.5. Recent Developments
  • 9.9. Eckert & Ziegler
    • 9.9.1. Overview
    • 9.9.2. Financials
    • 9.9.3. Product Portfolio
    • 9.9.4. Business Strategy
    • 9.9.5. Recent Developments
  • 9.10. BEBIG
    • 9.10.1. Overview
    • 9.10.2. Financials
    • 9.10.3. Product Portfolio
    • 9.10.4. Business Strategy
    • 9.10.5. Recent Developments

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Interventional Oncology Market, 2017–2025 (USD Million) 
4. Porter’s Five Forces Analysis
5. Interventional oncology market attractiveness analysis, by product
6. Interventional oncology market attractiveness analysis, by cancer type
7. Interventional oncology market: attractiveness analysis, by procedure
8. Interventional oncology market: attractiveness analysis, by region
9. Company market share analysis, 2018
10. Interventional oncology market revenue by product, 2018 and 2025
11. Interventional oncology market for embolization devices, 2017–2025 (USD Million)
12. Interventional oncology market for ablation devices, 2017–2025 (USD Million)
13. Interventional oncology market for support devices, 2017–2025 (USD Million)
14. Interventional oncology market revenue by cancer type, 2018 and 2025
15. Interventional oncology market revenue share by kidney, 2017–2025 (USD Million)
16. Interventional oncology market revenue share by lung, 2017–2025 (USD Million)
17. Interventional oncology market revenue share by breast, 2017–2025 (USD Million)
18. Interventional oncology market revenue share by liver, 2017–2025 (USD Million)
19. Interventional oncology market revenue share by bone metastasis, 2017–2025 (USD Million)
20. Interventional oncology market revenue share by others, 2017–2025 (USD Million)
21. Interventional oncology market revenue share by procedure, 2018 and 2025
22. Interventional oncology market revenue share by thermal tumor ablation, 2017–2025 (USD Million)
23. Interventional oncology market revenue share by non-thermal tumor ablation, 2017–2025 (USD Million)
24. Interventional oncology market revenue share by Transcatheter Arterial Chemoembolization, 2017–2025 (USD Million)
25. Interventional oncology market revenue share by Transcatheter Arterial Radioembolization, 2017–2025 (USD Million)
26. Interventional oncology market revenue share by Transcatheter Arterial Embolization, 2017–2025 (USD Million)
27. North America Interventional oncology market, 2017–2025 (USD Million)
28. Europe Interventional oncology market, 2017–2025 (USD Million)
29. Asia Pacific Interventional oncology market, 2017–2025 (USD Million)
30. Latin America Interventional oncology market,2017–2025 (USD Million)
31. The Middle East and Africa Interventional oncology market, 2017–2025 (USD Million)

Table Of Tables

List of Tables

1. Interventional oncology market: Snapshot
2. Drivers of the Interventional oncology market: Impact analysis
3. Restraints of the Interventional oncology market: Impact analysis
4. North America Interventional oncology market revenue, by product, 2017–2025 (USD Million)
5. North America interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
6. North America interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
7. The U.S. interventional oncology market revenue, by product, 2017–2025 (USD Million)
8. The U.S. interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
9. The U.S. interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
10. Canada interventional oncology market revenue, by product, 2017–2025 (USD Million)
11. Canada interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
12. Canada interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
13. Europe interventional oncology market revenue, by product, 2017–2025 (USD Million)
14. Europe interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
15. Europe interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
16. UK interventional oncology market revenue, by product, 2017–2025 (USD Million)
17. UK interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
18. UK interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
19. Germany interventional oncology market revenue, by product, 2017–2025 (USD Million)
20. Germany interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
21. Germany interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
22. France interventional oncology market revenue, by product, 2017–2025 (USD Million)
23. France interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
24. France interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
25. Rest of Europe interventional oncology market revenue, by product, 2017–2025 (USD Million)
26. Rest of Europe interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
27. Rest of Europe interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
28. Asia Pacific interventional oncology market revenue, by product, 2017–2025 (USD Million)
29. Asia Pacific interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
30. Asia Pacific interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
31. China interventional oncology market revenue, by product, 2017–2025 (USD Million)
32. China interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
33. China interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
34. Japan interventional oncology market revenue, by product, 2017–2025 (USD Million)
35. Japan interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
36. Japan interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
37. India interventional oncology market revenue, by product, 2017–2025 (USD Million)
38. India interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
39. India interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
40. Rest of Asia Pacific interventional oncology market revenue, by product, 2017–2025 (USD Million)
41. Rest of Asia Pacific interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
42. Rest of Asia Pacific interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
43. Latin America interventional oncology market revenue, by product, 2017–2025 (USD Million)
44. Latin America interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
45. Latin America interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
46. Brazil interventional oncology market revenue, by product, 2017–2025 (USD Million)
47. Brazil interventional oncology market revenue, by cancer type, 2017–2025 (USD Millions)
48. Brazil interventional oncology market revenue, by procedure, 2017-2025 (USD Millions)
49. Rest of Latin America interventional oncology market revenue, by product, 2017–2025 (USD Million)
50. Rest of Latin America interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
51. Rest of Latin America interventional oncology market revenue, by procedure, 2017–2025 (USD Million)
52. The Middle East and Africa interventional oncology market revenue, by product, 2017–2025 (USD Million)
53. The Middle East and Africa interventional oncology market revenue, by cancer type, 2017–2025 (USD Million)
54. The Middle East and Africa interventional oncology market revenue, by procedure, 2017–2025 (USD Million)